Clinical Trial Update: SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil [Phase 2]

View source ↗

Summary

SWOG-S9635, a Phase 2 trial evaluating fluorouracil plus ethynyluracil in advanced colorectal cancer that did not respond to fluorouracil, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ethynyluracil (ethynyluracil)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED